{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T10:55:08Z","timestamp":1759056908461,"version":"3.44.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004412","name":"Human Frontier Science Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.bbrc.2010.07.120","type":"journal-article","created":{"date-parts":[[2010,8,3]],"date-time":"2010-08-03T04:42:52Z","timestamp":1280810572000},"page":"593-599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Reduction of amyloid \u03b2-peptide accumulation in Tg2576 transgenic mice by oral vaccination"],"prefix":"10.1016","volume":"399","author":[{"given":"Rika","family":"Ishii-Katsuno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Katsuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Nojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene","family":"Futai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noboru","family":"Sasagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiji","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Ishiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2010.07.120_b0005","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2010.07.120_b0010","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev.pharmtox.43.100901.140248","article-title":"Alzheimer\u2019s disease: molecular understanding predicts amyloid-based therapeutics","volume":"43","author":"Selkoe","year":"2003","journal-title":"Ann. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bbrc.2010.07.120_b0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse","volume":"400","author":"Schenk","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2010.07.120_b0020","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/78682","article-title":"Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease","volume":"6","author":"Bard","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2010.07.120_b0025","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/1531-8249(200010)48:4<567::AID-ANA3>3.0.CO;2-W","article-title":"Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer\u2019s disease","volume":"48","author":"Weiner","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2010.07.120_b0030","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/35050110","article-title":"A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer\u2019s disease","volume":"408","author":"Janus","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2010.07.120_b0035","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/35050116","article-title":"A beta peptide vaccination prevents memory loss in an animal model of Alzheimer\u2019s disease","volume":"408","author":"Morgan","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2010.07.120_b0040","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/nm783","article-title":"Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease","volume":"8","author":"Hock","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2010.07.120_b0045","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0896-6273(03)00294-0","article-title":"Antibodies against beta-amyloid slow cognitive decline in Alzheimer\u2019s disease","volume":"38","author":"Hock","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2010.07.120_b0050","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","article-title":"Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization","volume":"61","author":"Orgogozo","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.bbrc.2010.07.120_b0055","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm840","article-title":"Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report","volume":"9","author":"Nicoll","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2010.07.120_b0060","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1073\/pnas.151261398","article-title":"Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer\u2019s disease","volume":"98","author":"DeMattos","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2010.07.120_b0065","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1126\/science.1067568","article-title":"Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer\u2019s disease","volume":"295","author":"DeMattos","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2010.07.120_b0070","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.vaccine.2004.12.015","article-title":"Induction of a Th2 immune response by co-administration of recombinant adenovirus vectors encoding amyloid beta-protein and GM-CSF","volume":"23","author":"Kim","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2010.07.120_b0075","doi-asserted-by":"crossref","first-page":"9619","DOI":"10.1073\/pnas.0600966103","article-title":"Nonviral Abeta DNA vaccine therapy against Alzheimer\u2019s disease: long-term effects and safety","volume":"103","author":"Okura","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2010.07.120_b0080","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbrc.2005.08.044","article-title":"Induction of anti-inflammatory immune response by an adenovirus vector encoding 11 tandem repeats of Abeta1\u20136: toward safer and effective vaccines against Alzheimer\u2019s disease","volume":"336","author":"Kim","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2010.07.120_b0085","doi-asserted-by":"crossref","first-page":"6737","DOI":"10.1016\/j.febslet.2005.11.003","article-title":"Transgenic potato expressing Abeta reduce Abeta burden in Alzheimer\u2019s disease mouse model","volume":"579","author":"Youm","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2010.07.120_b0090","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1089\/adt.2004.2.383","article-title":"Expression of amyloid-beta 1\u201340 and 1\u201342 peptides in Capsicum annum var. angulosum for oral immunization","volume":"2","author":"Szabo","year":"2004","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.bbrc.2010.07.120_b0095","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-5793(90)81121-4","article-title":"Production of enkephalin in tobacco protoplasts using tobacco mosaic virus RNA vector","volume":"269","author":"Takamatsu","year":"1990","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2010.07.120_b0100","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1128\/JVI.77.2.1452-1461.2003","article-title":"Defective tobamovirus movement protein lacking wild-type phosphorylation sites can be complemented by substitutions found in revertants","volume":"77","author":"Kawakami","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2010.07.120_b0105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00253-002-0986-8","article-title":"Construction of self-disruptive Bacillus megaterium in response to substrate exhaustion for polyhydroxybutyrate production","volume":"59","author":"Hori","year":"2002","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.bbrc.2010.07.120_b0110","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","article-title":"Long-term effects of A\u03b242 immunisation in Alzheimer\u2019s disease: follow-up of a randomized, placebo-controlled phase I trial","volume":"372","author":"Holmes","year":"2008","journal-title":"Lancet"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X10014531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X10014531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T10:51:33Z","timestamp":1757760693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X10014531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0006291X10014531"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2010.07.120","relation":{},"ISSN":["0006-291X"],"issn-type":[{"type":"print","value":"0006-291X"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction of amyloid \u03b2-peptide accumulation in Tg2576 transgenic mice by oral vaccination","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2010.07.120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}